Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system.

[1]  Johannes Berkhof,et al.  Combined CADM1 and MAL promoter methylation analysis to detect (pre‐)malignant cervical lesions in high‐risk HPV‐positive women , 2011, International journal of cancer.

[2]  M. von Knebel Doeberitz,et al.  Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation , 2011, PloS one.

[3]  J. Herman,et al.  Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! , 2011, Clinical Cancer Research.

[4]  R. Burk,et al.  Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. , 2011, Gynecologic oncology.

[5]  J. Edberg,et al.  A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia , 2011, Cancer.

[6]  D. Lim,et al.  HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. , 2010, Cancer research.

[7]  H. Lai,et al.  Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[8]  Saskia M Wilting,et al.  Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis , 2009, The Journal of pathology.

[9]  S. Krishna,et al.  Cell intrinsic & extrinsic factors in cervical carcinogenesis. , 2009, The Indian journal of medical research.

[10]  U. Landegren,et al.  Multiplex and quantifiable detection of nucleic acid from pathogenic fungi using padlock probes, generic real time PCR and specific suspension array readout. , 2009, Journal of microbiological methods.

[11]  P. Lizardi,et al.  Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. , 2009, Virology.

[12]  B. Vojtesek,et al.  Prediction of Human Papillomavirus 16 E6 Gene Expression and Cervical Intraepithelial Neoplasia Progression by Methylation Status , 2009, International Journal of Gynecologic Cancer.

[13]  A. Valencia,et al.  The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. , 2008, Genome research.

[14]  I. Nazarenko,et al.  A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP. , 2008, Journal of virological methods.

[15]  J. Berkhof,et al.  Association between dense CADM1 promoter methylation and reduced protein expression in high‐grade CIN and cervical SCC , 2008, The Journal of pathology.

[16]  H. Bernard,et al.  Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. , 2008, Virology.

[17]  S. Wacholder,et al.  High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease , 2007, International journal of cancer.

[18]  J. Berkhof,et al.  Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial , 2007, The Lancet.

[19]  Daisy R. Lee,et al.  Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. , 2006, Journal of virological methods.

[20]  Bornali Bhattacharjee,et al.  CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. , 2006, Virology.

[21]  J. Berkhof,et al.  Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33‐positive women with normal cytology , 2006, International journal of cancer.

[22]  Guifang Yu,et al.  Associations of high-risk HPV types and viral load with cervical cancer in China. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  Bornali Bhattacharjee,et al.  HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. , 2006, Gynecologic oncology.

[24]  S. Dunbar.  Applications of Luminex® xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detection , 2005, Clinica Chimica Acta.

[25]  C. Meijer,et al.  HPV-mediated transformation of the anogenital tract. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  H. Bernard,et al.  Conserved Methylation Patterns of Human Papillomavirus Type 16 DNA in Asymptomatic Infection and Cervical Neoplasia , 2004, Journal of Virology.

[27]  J. Kappes,et al.  Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer , 2004, Journal of Virology.

[28]  J. Wengel,et al.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. , 2004, Biochemistry.

[29]  C. Meijer,et al.  TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. , 2004, Journal of the National Cancer Institute.

[30]  P. Lambert,et al.  Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection , 2003, Journal of Virology.

[31]  C. Wheeler,et al.  CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression , 2003, Journal of Virology.

[32]  H. Bernard,et al.  A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16. , 2003, Virology.

[33]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[34]  J. D. Benson,et al.  Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways , 2000, The EMBO journal.

[35]  W. Rocque,et al.  The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity. , 2000, Virology.

[36]  J. R. Morris,et al.  Expression patterns of the human papillomavirus type 16 transcription factor E2 in low‐ and high‐grade cervical intraepithelial neoplasia , 1998, The Journal of pathology.

[37]  G. Steger,et al.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein , 1997, Journal of virology.

[38]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[39]  M. O’Connor,et al.  YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity , 1996, Journal of virology.

[40]  A. Clarke,et al.  CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences , 1996, Journal of virology.

[41]  D. McCance,et al.  Mapping of HPV-11 E1 binding site and determination of other important cis elements for replication of the origin. , 1996, Virology.

[42]  P. Howley,et al.  Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.

[43]  K. Gaston,et al.  CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. , 1995, Nucleic acids research.

[44]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Frattini,et al.  Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. M. Sanders,et al.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements. , 1994, Nucleic acids research.

[47]  H. Bernard,et al.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID , 1994, Journal of virology.

[48]  F. Hoppe-Seyler,et al.  Cellular control of human papillomavirus oncogene transcription , 1994, Molecular carcinogenesis.

[49]  L. Chow,et al.  Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements , 1994, Journal of virology.

[50]  D. McCance,et al.  Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin , 1993, Journal of virology.

[51]  A. Bird,et al.  Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein. , 1992, The EMBO journal.

[52]  P. Lambert.  Papillomavirus DNA replication , 1991, Journal of virology.

[53]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[54]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[55]  B. Gloss,et al.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element , 1990, Journal of virology.

[56]  Adrian Bird,et al.  Alternative chromatin structure at CpG islands , 1990, Cell.

[57]  W. Schaffner,et al.  Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. , 1988, Genes & development.

[58]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.

[59]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[60]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[61]  F. Thierry,et al.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. , 2011, American journal of cancer research.

[62]  Magnus von Knebel Doeberitz,et al.  Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. , 2008, Cancer research.

[63]  C. Meijer,et al.  HPV DNA detection and typing in cervical scrapes. , 2005, Methods in molecular medicine.

[64]  R. Hegde.  The papillomavirus E2 proteins: structure, function, and biology. , 2002, Annual review of biophysics and biomolecular structure.

[65]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[66]  J. Wahlfors,et al.  Automated fluorescent genomic sequencing as applied to the methylation analysis of the human ornithine decarboxylase gene. , 1994, DNA sequence : the journal of DNA sequencing and mapping.

[67]  D. Lowy,et al.  Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA , 1987, Nature.